<DOC>
	<DOCNO>NCT00687505</DOCNO>
	<brief_summary>The primary purpose study evaluate safety tolerability FP-1039 , new biologic treatment cancer .</brief_summary>
	<brief_title>Safety Study FP-1039 To Treat Cancer</brief_title>
	<detailed_description />
	<criteria>Subjects metastatic locally advanced unresectable solid tumor standard curative supportive measure exist longer effective Male female 18 year age old Presence history melanoma Primary brain tumor Presence history glaucoma</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
</DOC>